Cargando…

Development of Submacular Hemorrhage in Neovascular Age-related Macular Degeneration: Influence on Visual Prognosis in a Clinical Setting

PURPOSE: This study aimed to evaluate changes in visual acuity before and after the development of submacular hemorrhage secondary to neovascular age-related macular degeneration (AMD) and to compare the visual outcomes between patients with and without hemorrhage. METHODS: This retrospective observ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Young Suk, Kim, Jae Hui, Kim, Jong Woo, Kim, Chul Gu, Lee, Dong Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Ophthalmological Society 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182213/ https://www.ncbi.nlm.nih.gov/pubmed/30311458 http://dx.doi.org/10.3341/kjo.2017.0095

Ejemplares similares

Comparison of treatment methods for submacular hemorrhage in neovascular age-related macular degeneration: conservative versus active surgical strategy
por: Mun, Yongseok, et al.
Publicado: (2022)

The Efficacy of Intravitreal Aflibercept in Submacular Hemorrhage Secondary to Wet Age-related Macular Degeneration
por: Shin, Kyung-Hoon, et al.
Publicado: (2016)

Antiplatelet and anticoagulant therapy in patients with submacular hemorrhage caused by neovascular age-related macular degeneration
por: Weber, Constance, et al.
Publicado: (2022)

Visual prognosis of submacular hemorrhage secondary to age-related macular degeneration: A retrospective multicenter survey
por: Inoue, Naomi, et al.
Publicado: (2022)

Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor
por: Kim, Kun Hae, et al.
Publicado: (2015)

Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration
por: Nourinia, Ramin, et al.
Publicado: (2010)

Long-Term Outcome of Eyes with Vitrectomy for Submacular and/or Vitreous Hemorrhage in Neovascular Age-Related Macular Degeneration
por: Kawakami, Setsuko, et al.
Publicado: (2021)

Long-term Clinical Course after Vitrectomy for Breakthrough Vitreous Hemorrhage Secondary to Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy
por: Kim, Jae Hui, et al.
Publicado: (2020)

Risk factors for breakthrough vitreous hemorrhage after intravitreal anti-VEGF injection in age-related macular degeneration with submacular hemorrhage
por: Shin, Yong-Il, et al.
Publicado: (2018)

Subretinal Coapplication of Tissue Plasminogen Activator and Bevacizumab with Concurrent Pneumatic Displacement for Submacular Hemorrhages Secondary to Neovascular Age-Related Macular Degeneration
por: Avcı, Remzi, et al.
Publicado: (2021)

Location of submacular hemorrhage as a predictor of visual outcome after intravitreal ranibizumab for age-related macular degeneration
por: Karagiannis, Dimitrios, et al.
Publicado: (2017)

Long-Term Outcomes of Switching from Fixed-Dose to As-Needed Regimen for Treating Submacular Hemorrhage Secondary to Polypoidal Choroidal Vasculopathy
por: Kim, Jae Hui, et al.
Publicado: (2020)

Displacement of submacular hemorrhage associated with age-related macular degeneration using vitrectomy and submacular tPA injection followed by intravitreal ranibizumab
por: Sandhu, Sukhpal Singh, et al.
Publicado: (2010)

Intravitreal anti-VEGF monotherapy for thick submacular hemorrhage of less than 1 week duration secondary to neovascular age-related macular degeneration
por: Jain, Sachin, et al.
Publicado: (2013)

Increase in the Population of Patients with Neovascular Age-Related Macular Degeneration Who Underwent Long-Term Active Treatment
por: Baek, Seung Kook, et al.
Publicado: (2019)

Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration
por: Gök, Mustafa, et al.
Publicado: (2017)

Outer nuclear layer recovery as a predictor of visual prognosis in type 1 choroidal neovascularization of neovascular age-related macular degeneration
por: Lee, Seungheon, et al.
Publicado: (2023)

Author Correction: Increase in the Population of Patients with Neovascular Age-Related Macular Degeneration Who Underwent Long-Term Active Treatment
por: Baek, Seung Kook, et al.
Publicado: (2020)

Intravitreal anti-vascular endothelial growth factor monotherapy in age-related macular degeneration with submacular hemorrhage
por: Maruyama-Inoue, Maiko, et al.
Publicado: (2023)

Investigation of the Trend of Selecting Anti-Vascular Endothelial Growth Factor Agents for the Initial Treatment of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
por: Kim, Jae-Hui, et al.
Publicado: (2021)

Pneumatic displacement for management of traumatic macular hole with submacular hemorrhage
por: Mishra, Maithili, et al.
Publicado: (2020)

Visual Outcome after Vitrectomy with Subretinal tPA Injection to Treat Submacular Hemorrhage Secondary to Age-Related Macular Degeneration or Macroaneurysm
por: Ali Said, Yasmin, et al.
Publicado: (2021)

Pneumatic displacement and intravitreal bevacizumab for management of submacular hemorrhage in choroidal neovascular membrane
por: Agarwal, Manisha, et al.
Publicado: (2010)

Management of a Submacular Hemorrhage Secondary to Age-Related Macular Degeneration: A Comparison of Three Treatment Modalities
por: Jeong, Seongyong, et al.
Publicado: (2020)

Displacement of submacular hemorrhage secondary to age-related macular degeneration with subretinal injection of air and tissue plasminogen activator
por: Ogata, Maasa, et al.
Publicado: (2022)

Prechoroidal Cleft in Type 3 Neovascularization: Incidence, Timing, and Its Association with Visual Outcome
por: Kim, Jae Hui, et al.
Publicado: (2018)

Prediction of anti-vascular endothelial growth factor agent-specific treatment outcomes in neovascular age-related macular degeneration using a generative adversarial network
por: Moon, Sehwan, et al.
Publicado: (2023)

Submacular predominantly hemorrhagic choroidal neovascularization: resolution of bleedings under anti-VEGF therapy
por: Dimopoulos, Spyridon, et al.
Publicado: (2015)

Polypoidal Choroidal Vasculopathy in Korean Patients with Large Submacular Hemorrhage
por: Yoon, Jin Sook, et al.
Publicado: (2007)

Ranibizumab therapy for predominantly hemorrhagic neovascular age-related macular degeneration
por: Dikmetas, Ozlem, et al.
Publicado: (2022)

Comparison of 24-month treatment outcomes between as-needed treatment and switching to treat-and-extend in type 3 macular neovascularization
por: Kim, Jae Hui, et al.
Publicado: (2022)

Risk factors for breakthrough vitreous hemorrhage after intravitreal tissue plasminogen activator and gas injection for submacular hemorrhage associated with age related macular degeneration
por: Lim, Jun Hyun, et al.
Publicado: (2020)

Optical Coherence Tomographic Features and Prognosis of Pneumatic Displacement for Submacular Hemorrhage
por: Bae, Kunho, et al.
Publicado: (2016)

Traumatic Submacular Hemorrhage with Macular Hole Repaired by Pneumatic Displacement and Intravitreal t-PA Injection
por: Mehta, Amy A., et al.
Publicado: (2017)

Pneumatic displacement and intravitreal bevacizumab: A new approach for management of submacular hemorrhage in choroidal neovascular membrane
por: Chawla, Shobhit, et al.
Publicado: (2009)

Long-Term Favorable Visual Outcomes in Patients with Large Submacular Hemorrhage
por: Iyer, Prashanth G, et al.
Publicado: (2021)

Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age‐related macular degeneration in daily clinical practice: data from the FRB! registry
por: Gabrielle, Pierre‐Henry, et al.
Publicado: (2022)

Submacular hemorrhage secondary to congenital toxoplasmosis
por: Costa, Ana Luiza Fontes de Azevedo, et al.
Publicado: (2014)

The Mechanism of Gas in Submacular Hemorrhage [Letter]
por: Özyol, Erhan
Publicado: (2021)

Subretinal tissue plasminogen-assisted vitrectomy for posttraumatic full-thickness macular hole with submacular hemorrhage
por: Kumar, Pradeep, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i8h3vuhpvm9s6sn856o47br51b